Market Cap 30.91M
Revenue (ttm) 640,000.00
Net Income (ttm) -57.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9,028.13%
Debt to Equity Ratio 0.00
Volume 139,500
Avg Vol 220,828
Day's Range N/A - N/A
Shares Out 42.24M
Stochastic %K 32%
Beta -1.05
Analysts Sell
Price Target $1.00

Company Profile

Rallybio Corporation, a clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody which is in Phase II clinical trial for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT); and RLYB211 for the prevention of FNAIT. The company is also developing RLYB114, a pegylated complement factor 5 (C5)-tar...

Industry: Biotechnology
Sector: Healthcare
Phone: 203 859 3820
Address:
234 Church Street, Suite 1020, New Haven, United States
joe77w
joe77w Dec. 26 at 4:33 AM
$RLYB lets hope the best for clinical trial data for the benefit of patients and shareholders
0 · Reply
joe77w
joe77w Dec. 26 at 4:32 AM
$RLYB https://www.theglobeandmail.com/investing/markets/stocks/RLYB/pressreleases/35738295/rallybios-rlyb116-study-a-potential-game-changer-in-hematologic-and-autoimmune-disease-treatment/
0 · Reply
joe77w
joe77w Dec. 26 at 4:31 AM
$RLYB https://clinicaltrials.gov/study/NCT06797375?term=Rlyb116&rank=1
0 · Reply
VolckerRuleV
VolckerRuleV Dec. 25 at 10:21 AM
$RLYB Expectations reset as evidence replaces narrative, as investors weigh durability over pace. Delivery cadence is becoming the real competitive edge.
0 · Reply
estatebuyersmia
estatebuyersmia Dec. 24 at 6:55 PM
$RLYB MERRY CHRISTMAS TO ALL THE BULLS, SCREW ALL THE BEARS... 2026 IS $RLYB YEAR.
0 · Reply
Love_To_Learn
Love_To_Learn Dec. 24 at 1:33 PM
$RLYB CHANGED FEW THINGS ON U SHORT TERM SO
1 · Reply
BiotechValues
BiotechValues Dec. 23 at 10:33 PM
$RLYB who wants my shares? Place a bid tomorrow or Friday and you can have them!
2 · Reply
SDBiotechInvestor
SDBiotechInvestor Dec. 23 at 10:14 PM
$RLYB - Expecting data first business week of January.
0 · Reply
BiotechValues
BiotechValues Dec. 22 at 5:51 PM
$RLYB trades like such a turd, own some, but this is like watching paint dry. No interest whatsoever, so hopefully not a bad sign.
2 · Reply
joe77w
joe77w Dec. 21 at 6:50 PM
$RLYB 5 mln USD from RECURSION due in 2026 when pH 1 started
0 · Reply
Latest News on RLYB
Why Is Microcap Rallybio Stock Trading Higher On Tuesday?

Jul 8, 2025, 9:44 AM EDT - 6 months ago

Why Is Microcap Rallybio Stock Trading Higher On Tuesday?


National Vision Releases 2023 Sustainability Report

Aug 27, 2024, 8:00 AM EDT - 1 year ago

National Vision Releases 2023 Sustainability Report

ACNT


Rallybio to Present at Upcoming Investor Conferences

Aug 27, 2024, 8:00 AM EDT - 1 year ago

Rallybio to Present at Upcoming Investor Conferences


Rallybio: Gearing Up To Be An Opportunity

Sep 15, 2023, 5:15 PM EDT - 2 years ago

Rallybio: Gearing Up To Be An Opportunity


joe77w
joe77w Dec. 26 at 4:33 AM
$RLYB lets hope the best for clinical trial data for the benefit of patients and shareholders
0 · Reply
joe77w
joe77w Dec. 26 at 4:32 AM
$RLYB https://www.theglobeandmail.com/investing/markets/stocks/RLYB/pressreleases/35738295/rallybios-rlyb116-study-a-potential-game-changer-in-hematologic-and-autoimmune-disease-treatment/
0 · Reply
joe77w
joe77w Dec. 26 at 4:31 AM
$RLYB https://clinicaltrials.gov/study/NCT06797375?term=Rlyb116&rank=1
0 · Reply
VolckerRuleV
VolckerRuleV Dec. 25 at 10:21 AM
$RLYB Expectations reset as evidence replaces narrative, as investors weigh durability over pace. Delivery cadence is becoming the real competitive edge.
0 · Reply
estatebuyersmia
estatebuyersmia Dec. 24 at 6:55 PM
$RLYB MERRY CHRISTMAS TO ALL THE BULLS, SCREW ALL THE BEARS... 2026 IS $RLYB YEAR.
0 · Reply
Love_To_Learn
Love_To_Learn Dec. 24 at 1:33 PM
$RLYB CHANGED FEW THINGS ON U SHORT TERM SO
1 · Reply
BiotechValues
BiotechValues Dec. 23 at 10:33 PM
$RLYB who wants my shares? Place a bid tomorrow or Friday and you can have them!
2 · Reply
SDBiotechInvestor
SDBiotechInvestor Dec. 23 at 10:14 PM
$RLYB - Expecting data first business week of January.
0 · Reply
BiotechValues
BiotechValues Dec. 22 at 5:51 PM
$RLYB trades like such a turd, own some, but this is like watching paint dry. No interest whatsoever, so hopefully not a bad sign.
2 · Reply
joe77w
joe77w Dec. 21 at 6:50 PM
$RLYB 5 mln USD from RECURSION due in 2026 when pH 1 started
0 · Reply
Lyn30
Lyn30 Dec. 19 at 6:39 PM
$RLYB I don’t care. I do only care if sp move or not and buy a stock on that basis
0 · Reply
Ataifanboymentalhealthz
Ataifanboymentalhealthz Dec. 19 at 6:34 PM
$RLYB all bio is risky. Risk here is if they can get pk data right. Efficacy partial in question but less risky because c5 inhibitors already approved for complement mediated disorders. We need to see if higher 300 mg dose from company is safe
0 · Reply
Lyn30
Lyn30 Dec. 19 at 12:39 AM
$RLYB I bought this stock @.56. There is one bear continuously posting scam here. My point is here if u go any penny stock board u may see same story. I always block those cause I don’t buy any stock depends on what others say and I always say same thing do ur own dd don’t listen to bulls or bears.
1 · Reply
skyrockets_Inc
skyrockets_Inc Dec. 18 at 3:57 PM
$RLYB Bought 50k more share this a.m. Still believe data likely to be before Tue of next week.... Data pushing to the last minute could be because of what I said below, or it could be from a strategic deal coming like an acquisition/partner/RM. Either way, cash is still sitting at $1.50/share so seems like a safe downside risk play no matter what imo. And the fact that all of the original VCs are still holding their mega bag positions points that an exit liquidity event is likely coming soon. Buying more daily :)
2 · Reply
estatebuyersmia
estatebuyersmia Dec. 17 at 6:10 PM
$ABCL ED_NG ALL MY BIOTECH STOCKS ARE DOING REALLY WELL $RXRX $ABCL $CABA $RLYB.... YOUR PREDICTIONS MEAN SHIT....
1 · Reply
skyrockets_Inc
skyrockets_Inc Dec. 17 at 3:59 PM
$VYNE to all my VYNE longs it's been a pleasure riding this one out w/ you. My 0.36 avg sold out today at 0.73 for 100%+ profit. Good luck to all of you on your next venture. I'm off to $RLYB next. News coming this week likely.
1 · Reply
skyrockets_Inc
skyrockets_Inc Dec. 17 at 2:34 PM
$RLYB Just bought 24k more. News likely this week. Still trading at half-cash. Downside risk seems limited.
0 · Reply
skyrockets_Inc
skyrockets_Inc Dec. 17 at 1:41 PM
$VYNE Nice win yet again! Called it! Time to buy more $CYCN and $RLYB
3 · Reply
isu2b3vrysus
isu2b3vrysus Dec. 16 at 2:41 PM
0 · Reply
SDBiotechInvestor
SDBiotechInvestor Dec. 11 at 10:53 PM
$RLYB - interesting theory. CEO of $RLYB is former head of research at Alexion (now part of AstraZeneca). Alexion specialized in C5 inhibitors and has one recently approved (ravulizumab). So, AstraZeneca has two FDA approved C5 inhibitors thanks to Alexion and is investing in multiple more programs. Makes sense that they absorb $RLYB given their huge investment in C5 programs and infrastructure. We will see!
3 · Reply
estatebuyersmia
estatebuyersmia Dec. 11 at 9:53 PM
0 · Reply
SDBiotechInvestor
SDBiotechInvestor Dec. 11 at 7:07 PM
$RLYB has FIVE very underwater VCs. I've seen many deals done with these guys when in situations like this.
0 · Reply